Price range: $79.00 through $270.00
Disclaimer: This is a research chemical only. It’s not a medication, and it’s not approved for human or animal use outside of authorized studies
| Sequence | Tyr‑{Aib}‑Glu‑Gly‑Thr‑Phe‑Thr‑Ser‑Asp‑Tyr‑Ser‑Ile‑{Aib}‑Leu‑Asp‑Lys‑Ile‑Ala‑Gln‑{diacid‑C20‑γ‑Glu‑(AEEA)₂‑Lys}‑Ala‑Phe‑Val‑Gln‑Trp‑Leu‑Ile‑Ala‑Gly‑Gly‑Pro‑Ser‑Ser‑Gly‑Ala‑Pro‑Pro‑Pro‑Ser‑NH₂ (Tirzepatide, 39 aa peptide with C20 fatty acid) |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | ~4813.5 Da |
| PubChem CID | 156588324 |
| CAS # | 2023788‑19‑2 |
In research models, Tirzepatide is being investigated for its ability to enhance insulin sensitivity, suppress glucagon secretion, delay gastric emptying, and reduce appetite—all while supporting glucose homeostasis. Its synergistic receptor activity aims to replicate and amplify the body’s natural hormonal responses to food intake and energy expenditure.
Early studies in preclinical and simulated environments have shown promising outcomes in reducing HbA1c levels, lowering body weight, and improving lipid metabolism. Scientists are particularly focused on Tirzepatide’s dual-action approach, which may yield greater metabolic effects than traditional single-pathway peptides, making it a significant compound in the exploration of complex conditions such as obesity and type 2 diabetes
| MG | 10MG, 20MG, 30MG, 50MG |
|---|
Reviews
There are no reviews yet.